A Multivariate prediction model for amlodipine therapeutic efficacy in pediatric primary hypertension
BackgroundThere are currently no biomarker-based prediction models for amlodipine therapeutic efficacy in pediatric hypertension. This study aimed to identify potential biomarkers and establish a biomarker-based model for predicting amlodipine therapeutic efficacy in pediatric primary hypertension (...
Saved in:
Main Authors: | Yao Lin, Hui Wang, Yaqi Li, Yang Liu, Yanyan Liu, Hongwei Zhang, Yanjun Deng, Lin Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1542276/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, Randomized Controlled Trial
by: Hongjie Chi, et al.
Published: (2025-01-01) -
Etiology and Medication of Hospitalized Children With Hypertension: A Retrospective Study
by: Chenhong Jia, et al.
Published: (2025-01-01) -
Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
by: Eirik Olsen, et al.
Published: (2025-02-01) -
Efficacy of Olmesartan/Amlodipine Single‐Pill Combination on 24‐h Mean Systolic Blood Pressure Measured by Ambulatory Monitoring in Non‐Responders to Valsartan or Candesartan Monotherapy
by: Woo‐Baek Chung, et al.
Published: (2025-01-01) -
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trial
by: Xiexiong Zhao, et al.
Published: (2025-01-01)